Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Hackensack, NJ
SEC filing record 1 source field available
Fiscal year end
31 December
Protalix BioTherapeutics, Inc. has filed 957 SEC EDGAR filings since 13 Aug 1996

SEC filing history

Showing 651-671 of 671 matching filings.

Per page
25
Current page
27
8-K File 001-33357

FORM 8-K

Filing date
18 May 2010
Reporting date
17 May 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-33357

FORM 10-Q

Filing date
10 May 2010
Reporting date
31 Mar 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
4

MAIN DOCUMENT DESCRIPTION

Filing date
03 May 2010
Reporting date
29 Apr 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33357

FORM 8-K

Filing date
27 Apr 2010
Reporting date
27 Apr 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
4

MAIN DOCUMENT DESCRIPTION

Filing date
16 Apr 2010
Reporting date
14 Apr 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
4

MAIN DOCUMENT DESCRIPTION

Filing date
25 Mar 2010
Reporting date
25 Feb 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33357

FORM 8-K

Filing date
17 Mar 2010
Reporting date
17 Mar 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
CT ORDER File 001-33357

CT ORDER filing

Filing date
15 Mar 2010
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33357

FORM 8-K

Filing date
09 Mar 2010
Reporting date
09 Mar 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33357

FORM 8-K

Filing date
03 Mar 2010
Reporting date
03 Mar 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
4

MAIN DOCUMENT DESCRIPTION

Filing date
26 Feb 2010
Reporting date
25 Feb 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
4

MAIN DOCUMENT DESCRIPTION

Filing date
26 Feb 2010
Reporting date
25 Feb 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
4

MAIN DOCUMENT DESCRIPTION

Filing date
26 Feb 2010
Reporting date
25 Feb 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
4

MAIN DOCUMENT DESCRIPTION

Filing date
26 Feb 2010
Reporting date
25 Feb 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K File 001-33357

FORM 10-K

Filing date
26 Feb 2010
Reporting date
31 Dec 2009
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-50118

DOC ONE

Filing date
16 Feb 2010
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33357

FORM 8-K

Filing date
11 Feb 2010
Reporting date
11 Feb 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
4

MAIN DOCUMENT DESCRIPTION

Filing date
09 Feb 2010
Reporting date
07 Feb 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33357

FORM 8-K

Filing date
05 Feb 2010
Reporting date
04 Feb 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33357

FORM 8-K

Filing date
02 Feb 2010
Reporting date
02 Feb 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33357

FORM 8-K

Filing date
14 Jan 2010
Reporting date
13 Jan 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .